Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$327,701,942
+$6,105,413 QoQ
Shares Held
904,954
-1.0% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#63
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $4,800,494,597 across 17 Drug Manufacturers - General names. AMGN ranks #5 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,333,307 | $1,599,208,548 | |
| 2 | JNJ |
Johnson & Johnson
|
3,780,752 | $960,197,585 | |
| 3 | ABBV |
AbbVie Inc.
|
2,733,648 | $687,895,182 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,809,518 | $489,523,063 | |
| 5 | AMGN |
Amgen Inc
This page
|
904,954 | $327,701,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,051,819 | $259,226,812 | |
| 7 | PFE |
Pfizer Inc
|
8,609,603 | $207,319,240 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,347,347 | $192,874,134 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $327,701,942 | 904,954 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $321,596,529 | 914,016 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $304,746,885 | 931,065 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $270,389,930 | 958,150 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $269,391,580 | 964,835 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $305,206,530 | 979,639 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $261,375,526 | 1,002,822 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $327,777,144 | 1,017,278 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $331,736,601 | 1,061,727 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $301,926,231 | 1,061,924 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $306,516,932 | 1,064,221 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $285,221,818 | 1,061,251 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $233,185,163 | 1,050,289 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $250,997,904 | 1,038,254 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $263,063,638 | 1,001,613 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $218,883,911 | 971,091 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $225,071,234 | 925,077 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $228,828,220 | 946,275 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $212,749,854 | 945,681 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $198,254,020 | 932,302 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $240,418,181 | 986,331 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $259,116,954 | 1,041,425 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $261,996,828 | 1,139,513 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $295,200,740 | 1,161,476 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $263,522,840 | 1,117,285 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $210,227,563 | 1,036,983 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||